AMD, Absci and AI

AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips
The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.
AMD invests $20M in AI-powered drug discovery company Absci
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop new hardware and software optimized for the healthcare sector. The effort will place particular emphasis on developing technologies that can advance drug discovery.
AMD invests $20 million in AI drug research at Vancouver-based Absci
Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial intelligence to develop new drug therapies.
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices Inc (NASDAQ:AMD) to enhance its AI drug discovery capabilities.
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power critical AI drug discovery workloads,
Where Will AMD Stock Be in 3 Years?
The PC market endured double-digit declines in 2022 and 2023. The good news for AMD is that the market stabilized in 2024, ...
Hosted on MSN5h
AMD chips now power 55 percent of Puget Systems systems — AMD makes big inroads in professional systems
Puget Systems, a custom computer building company specializing in configuring workstations for professional users, has ...
Why Advanced Micro Devices (AMD) Could Outperform Nvidia in 2025
Nvidia (NVDA) was the big winner in the AI space during 2024 as it solidified its lead in GPUs, which led to a 185% stock ...
AMD: An Attractive Valuation Despite AI Skepticism
Read here for an update on AMD's product roadmap, AI hardware challenges, valuation, and market sentiment for potential ...
itc.ua2d
AMD told the press about the RX 9070 and RDNA 4 graphics cards, but «forgot» them at the presentation — company explanation
The surprise of AMD's presentation at CES 2025 on January 6 was the absence of a report on the Radeon RX 9070 video cards and ...
AMD's first RDNA 4 GPU die pictured: Navi 48 around 390 mm2, targeting mainstream gamers
AMD's Navi 48 graphics processing unit, based on the RDNA 4 architecture that the company briefly demonstrated yesterday, is ...
AMD: Stop The Wishful Thinking And Face The Reality
Advanced Micro Devices faces AI hurdles and tech lag. Read why AMD stock may struggle as custom silicon and competition from ...
I tried FSR 4 on a new AMD Radeon RX 9070 XT graphics card, and it looks great
We tested AMD's latest AI resolution upscaling tech on its new gaming GPU with Ratchet & Clank, and it looks massively better ...